2012•Zhongguo jiceng yiyaoRequires access

The change of inflammatory response factor coronary heart disease patients with different stent after implantation operation

Zhao-wu Deng

Open publisher page 0 citations

Abstract

Objective To observe the influence of different stent after implantation operation on the serum level of interleukin 6( IL-6 ),interleukin 18 (IL-18),C-reactive protein(CRP) in patients with coronary heart disease.Methods The coronary heart disease patients with stent implantation operation were divided into two groups:bare stent group and paclitaxel eluting stent group.All the patients were taken blood from peripheral.The serum level of CRP,IL-6and IL-18of in all patients were detected before operation and 24h,48h,72h and 7d after operation.Results The peak levels of CRP,IL-6 and IL-18 in paclitaxel eluting stent group was ( 11.25 ± 2.15 ) mg/L,( 8.91 ± 2.31 ) μg/L,(0.95 ±0.16) μg/L,respectively,and significant lower than those in bare stent group[ ( 15.56 ± 3.37) mg/L,( 12.35 ±3.12) μg/L,(1.15 ±0.18) μg/L] (all P<0.05).Following up 6 months after operation,the rate of restenosis occurrence in paclitaxel duting stent group was 7.5%,and significant lower than that in bare stent group(26.3% ).Conclusion The paclitaxel eluting stent could reduce the seriousness of causing vasculitis and the restenosis occurrence after stenting. Key words: Coronary disease;  Stents, Paclitaxel;  Interleukin;  C - reactive protein

About this research paper

What this paper is about

Objective To observe the influence of different stent after implantation operation on the serum level of interleukin 6( IL-6 ),interleukin 18 (IL-18),C-reactive protein(CRP) in patients with coronary heart disease.Methods The coronary heart disease patients with stent implantation operation were divided into two groups:bare stent group and paclitaxel eluting stent group.All the patients were taken blood from peripheral.The serum level of CRP,IL-6and IL-18of in all patients were detected before operation and 24h,48h,72h and 7d after operation.Results The peak levels of CRP,IL-6 and IL-18 in paclitaxel eluting stent group was ( 11.25 ± 2.15 ) mg/L,( 8.91 ± 2.31 ) μg/L,(0.95 ±0.16) μg/L,respectively,and significant lower than those in bare stent group[ ( 15.56 ± 3.37) mg/L,( 12.35 ±3.12) μg/L,(1.15 ±0.18) μg/L] (all P<0.05).Following up 6 months after operation,the rate of restenosis occurrence in paclitaxel duting stent group was 7.5%,and significant lower than that in bare stent group(26.3% ).Conclusion The paclitaxel eluting stent could reduce the seriousness of causing vasculitis and the restenosis occurrence after stenting. Key words: Coronary disease;  Stents, Paclitaxel;  Interleukin;  C - reactive protein

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the influence of different stent after implantation operation on the serum level of interleukin 6( IL-6 ),interleukin 18 (IL-18),C-reactive protein(CRP) in patients with coronary heart disease.Methods The coronary heart disease patients with stent implantation operation were divided into two groups:bare stent group and paclitaxel eluting stent group.All the patients were taken blood from peripheral.The serum level of CRP,IL-6and IL-18of in all patients were detected before operation and 24h,48h,72h and 7d after operation.Results The peak levels of CRP,IL-6 and IL-18 in paclitaxel eluting stent group was ( 11.25 ± 2.15 ) mg/L,( 8.91 ± 2.31 ) μg/L,(0.95 ±0.16) μg/L,respectively,and significant lower than those in bare stent group[ ( 15.56 ± 3.37) mg/L,( 12.35 ±3.12) μg/L,(1.15 ±0.18) μg/L] (all P<0.05).Following up 6 months after operation,the rate of restenosis occurrence in paclitaxel duting stent group was 7.5%,and significant lower than that in bare stent group(26.3% ).Conclusion The paclitaxel eluting stent could reduce the seriousness of causing vasculitis and the restenosis occurrence after stenting. Key words: Coronary disease;  Stents, Paclitaxel;  Interleukin;  C - reactive protein

Key concepts: Medicine, Stent, Restenosis, Cardiology, Paclitaxel, Internal medicine, Interleukin 6, C-reactive protein

Related papers

Back to paper searchBrowse research topicsOriginal source
The change of inflammatory response factor coronary heart disease patients with different stent after implantation operation — Research Paper | ScholarLens